Market Overview

According to fortune business insights, the global medical device reprocessing market size was valued at USD 4.50 billion in 2025. The market is projected to grow from USD 4.84 billion in 2026 to USD 7.80 billion by 2034, exhibiting a CAGR of 6.1% during the forecast period. North America dominated the global market with a market share of 44.66% in 2025.

The analysis shows that market growth is driven by the increasing volume of surgical and diagnostic procedures, coupled with pressure on healthcare systems to contain costs, which is leading to a growing preference for reprocessed medical devices.

Major Players Profiled in the Market Report:

• STERIS (U.S.)
• Stryker (U.S.)
• Johnson & Johnson Services, Inc. (South Korea)
• Medline Industries, Inc. (U.S.)
• Life Science Outsourcing, Inc. (U.S.)
• Jabil Inc. (U.S.)
• Vanguard AG (Germany)
• Cardinal Health (U.S.)
• 3M (U.S.)
• NEScientific, Inc. (U.S.)

Segments

Increasing Adoption of Reusable Medical Devices to Propel Segment Growth

Based on product, the market is classified into reusable and single use. The reusable segment holds the largest market share due to the increasing prevalence of chronic conditions, a growing number of surgical procedures, and the fact that many hospitals maintain in-house sterile processing capabilities for these devices.

Prevalence of Healthcare-Associated Infections to Drive Disinfection & Sterilization Segment

By service type, the market is segmented into cleaning & decontamination, disinfection & sterilization, and storage & distribution. The disinfection & sterilization segment leads the market owing to the rising prevalence of healthcare-associated infections, which drives the demand for advanced services for reused medical devices.

Critical Devices Segment Dominance Owed to High Surgical Volumes